Vaccine maker Moderna will trim roughly 10% of its global workforce in 2025, reducing headcount to below 5,000 as sales decline and the firm seeks savings.
The French biotech is set to lose 30% of its employees as it focuses on its highest-value assets.
Nov 13, 2025
Vaccine developer Valneva announced the closure of its R&D site in Nantes, France, eliminating 30 of the 39 positions at that location as part of a consolidation strategy
Nov 12, 2025
Gilead Sciences subsidiary Kite Pharma is cutting 17 positions effective January 16, 2026 in Oceanside, California due to a paused expansion of biologics manufacturing operations, with work redirected to the Foster City...
Nov 5, 2025
Merck announced layoffs affecting 204 employees at its Rahway, New Jersey facility. These terminations will take place between February 20 and May 11, 2026, continuing the company's cost-saving strategy announced in...
Nov 5, 2025
Systemwide workforce reduction affecting entire health network including Lehigh Valley Health Network. Second round of job cuts in 2025, following $195 million operating loss
Nov 2, 2025
Bristol Myers Squibb announced another round of layoffs affecting 110 employees at its Lawrence Township, New Jersey site, with terminations to take effect in February and March 2026. This is part of the company's...
Oct 22, 2025
Sonoma Biotherapeutics, a clinical-stage biotechnology company developing regulatory T cell therapies, is reducing its workforce with an undisclosed number of employees affected. The company confirmed that roles across...
Oct 21, 2025
Neurology biotech Voyager Therapeutics laid off 30 employees following Novartis' discontinuation of two discovery-stage programs from their partnership. The layoffs come as the company evaluates its business needs to...
Oct 13, 2025